Disc Medicine Q2 EPS $(1.54) Beats $(1.77) Estimate
Disc Medicine (NASDAQ:IRON) reported quarterly losses of $(1.54) per share which beat the analyst consensus estimate of $(1.77) by 12.99 percent. This is a 2.53 percent increase over losses of $(1.58) per share from the
Disc Medicine lost less money per share than people expected, which is good news. When a company loses less than forecast, it shows they're managing their spending better than investors thought they would.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.